U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07545980) titled 'CelluJuve(R) for the Treatment of Moderate to Severe NLFs' on April 15.
Brief Summary: Single-center, open-label proof of concept study assessing the safety and effectiveness of CelluJuve(R) for the treatment of moderate to severe NLFs
Study Start Date: April 29
Study Type: INTERVENTIONAL
Condition:
Nasolabial Fold Wrinkles
Intervention:
DEVICE: CelluJuve(R)
CelluJuve(R)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Spiderwort Biotechnologies Inc.
Disclaimer: Curated by HT Syndication....